Abstract. In this paper, we develop a set of data processing algorithms for generating textured facade meshes of cities from a series of vertical 2D surface scans and camera images, obtained by a laser scanner and digital camera while driving on public roads under normal traffic conditions. These processing steps are needed to cope with imperfections and non-idealities inherent in laser scanning systems such as occlusions and reflections from glass surfaces. The data is divided into easy-to-handle quasi-linear segments corresponding to approximately straight driving direction and sequential topological order of vertical laser scans; each segment is then transformed into a depth image. Dominant building structures are detected in the depth images, and points are classified into foreground and background layers. Large holes in the background layer, caused by occlusion from foreground layer objects, are filled in by planar or horizontal interpolation. The depth image is further processed by removing isolated points and filling remaining small holes. The foreground objects also leave holes in the texture of building facades, which are filled by horizontal and vertical interpolation in low frequency regions, or by a copy-paste method otherwise. We apply the above steps to a large set of data of downtown Berkeley with several million 3D points, in order to obtain texture-mapped 3D models.
Melatonin is widely used for sleep disorders in patients with a range of developmental disorders and neurodisabilities, who also frequently have epilepsy. The aim of our review was to examine published data to assess the evidence for melatonin affecting seizure control. The literature search revealed 26 papers apparently reporting an association between melatonin and epilepsy or seizures but seven of these did not provide relevant information. Of the three double-blind, randomised, controlled trials, two showed no overall worsening or improvement in seizures, and one recent trial reported a statistically significant reduction in seizures. The open studies reported conflicting results. The few studies on the effect of seizures on melatonin levels have reported that baseline melatonin levels may be low in patients with uncontrolled epilepsy and that levels increase markedly following seizures. The striking finding of this review is the paucity of relevant data from the remarkably small number of studies. These results allow no firm conclusions to be drawn, although it would seem reasonable to observe that there was no marked overall effect on seizures, neither improvement nor worsening. There is a need for large, well designed, randomised, double-blind, placebo-controlled trials to establish the role of melatonin in either predisposing to or decreasing the likelihood of seizures.
Axillary levels I and II (lower axilla) receive substantial amount of incidental radiation doses with all the three techniques; however, conformal techniques (IMRT, 3DCRT) deliver significantly lesser incidental radiation to lower axilla than ST technique.
Nowadays, microgrids with hybrid renewable energy sources are increasing, and it is a promising solution to electrify remote areas where distribution network expansion is not feasible or economical. This study aims to find an ideal hybrid system grounded on solar, wind, diesel, biomass, hydro, and battery. This study utilizes the hybrid optimization model for electric renewable (HOMER) software to size the important components, perform technical, financial evaluation, renewable factor, estimate the harmful emissions, and sensitivity analysis. For optimum system selection, the lowest cost of energy is used as the criteria. Four different configurations of renewable energy sources are analyzed and found PV-WT-MH-CT-BT-DG-BG is the most feasible hybrid system amongst all configurations. The proposed PV-WT-MH-CT-BT-DG-BG hybrid system is more economic as the lowest cost of energy 0.
Early TEP is a reliable predictor of moderate-severe MRI injury in encephalopathic infants undergoing TH and may enable early stratification of infants who may benefit from adjuvant therapeutic interventions.
PurposeMalignant obstructive jaundice (MOJ) is relieved by stenting via endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic cholangiography and biliary drainage (PTCD). Stent occlusion rates of 30-45% have been reported in literature due to tumor ingrowth or overgrowth. We prospectively evaluated the feasibility and the role of intraluminal brachytherapy (ILBT) in preventing stent blockage in patients with MOJ after PTCD and stenting.Material and methodsTwelve patients with MOJ who underwent PTCD followed by self expanding metallic stent (SEMS) placement were prospectively enrolled in this study. Written informed consent was obtained. Intraluminal brachytherapy was done once patient was stable and serum bilirubin was less than 2 mg% or 50% of baseline value. On the day of ILBT, 6 French brachytherapy catheters were placed across malignant stricture under fluoroscopic guidance with placement of the tip 1 cm distal to stricture. A dose of 10 to 14 Gy was delivered at 1 cm from central axis of the source. Suitable patients also received external beam radiotherapy (EBRT) with weekly concurrent chemotherapy.ResultsAll patients tolerated the procedure well with minimal acute and late toxicities. Duodenal ulceration was observed in 1 patient. At a mean follow up of 10.25 months (5-24 months), stents were patent in 10/12 subjects and stent patency duration of 9.8 months (5-22) was reported.ConclusionsIntraluminal brachytherapy post PTCD is feasible and effective in preventing stent occlusion with minimal acute and late toxicities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.